Biophysical characterization and formulation of F1-V, a recombinant plague antigen

Journal of Pharmaceutical Sciences

Volumn 98, Issue 8, 2009, Pages 2592-2602

  D'Souza, Ajit Joseph M ^a   Ford, Brandi M ^a   Mar, Kevin D ^a   Sullivan, Vince J ^a  

^a BD Technologies   (United States)

Author keywords

Biotechnology; Circular dichroism; F1 V; Fluorescence spectroscopy; Light scattering; Plague; Protein aggregation; Protein formulation; Vaccine

Indexed keywords

ARGININE; DIMER; F1 V ANTIGEN; GUANIDINE; MAGNESIUM ION; MONOMER; OLIGOMER; RECOMBINANT ANTIGEN; SURFACTANT; UNCLASSIFIED DRUG; UREA;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG CONFORMATION; DRUG FORMULATION; DRUG SOLUBILITY; GEL PERMEATION CHROMATOGRAPHY; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR WEIGHT; PH; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RENATURATION;

EID: 68249088906     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21652     Document Type: Article

References (30)

1. Andrews GP, Heath DG, Anderson GW, Jr., Welkos SL, Friedlander AM. 1996. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64:2180-2187.
2. Tito MA, Miller J, Griffin KF, Williamson ED, Titball RW, Robinson CV. 2001. Macromolecular organization of the Yersinia pestis capsular F1 antigen: Insights from time-of-flight mass spectrometry. Protein Sci 10:2408-2413. (Pubitemid 32988656)
3. Simpson WJ, Thomas RE, Schwan TG. 1990. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg 43:389-396.
4. Anderson GW, Jr., Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 64:4580-4585.
5. Nakajima R, Brubaker RR. 1993. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 61:23-31. (Pubitemid 23015395)
6. Nakajima R, Motin VL, Brubaker RR. 1995. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63:3021-3029.
7. Une T, Brubaker RR. 1984. Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133:2226-2230. (Pubitemid 14033058)
8. Motin VL, Nedialkov YA, Brubaker RR. 1996. V antigen-polyhistidine fusion peptide: Binding to LcrH and active immunity against plague. Infect Immun 64:4313-4318.
9. 2+ response, and virulence of Yersinia pestis. J Bacteriol 177:2530-2542.
10. 2+ response virulence genes. J Bacteriol 173:2649-2657.
11. Heath DG, Anderson GW, Jr., Mauro JM, Welkos SL, Andrews GP, Adamovicz J, Friedlander AM. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137. (Pubitemid 28307882)
12. Miller J, Williamson ED, Lakey JH, Pearce MJ, Jones SM, Titball RW. 1998. Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. FEMS Immunol Med Microbiol 21:213-221. (Pubitemid 28356843)
13. Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ. 2005. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 21:1490-1510. (Pubitemid 41443005)
14. Uversky VN. 2002. Natively unfolded proteins: A point where biology waits for physics. Protein Sci 11:739-756.
15. Whitaker JR. 1963. Determination of molecular weights of proteins by gel filtration on Sephadex. Anal Chem 35:1950-1953.
16. Pearse A. 1980. Histochemistry, theoretical and applied, 4 edition. Edinburgh: Churchill Livingstone.
17. Millett IS, Doniach S, Plaxco KW. 2002. Toward a taxonomy of the denatured state: Small angle scattering studies of unfolded proteins. Adv Protein Chem 62:241-262. (Pubitemid 35204872)
18. Sreerama N, Venyaminov SY, Woody RW. 2000. Estimation of protein secondary structure from circular dichroism spectra: Inclusion of denatured proteins with native proteins in the analysis. Anal Biochem 287:243-251. (Pubitemid 32006233)
19. Ali V, Prakash K, Kulkarni S, Ahmad A, Madhusudan KP, Bhakuni V. 1999. 8-anilino-1-naphthalene sulfonic acid (ANS) induces folding of acid unfolded cytochrome c to molten globule state as a result of electrostatic interactions. Biochemistry 38:13635-13642. (Pubitemid 129515689)
20. Matulis D, Lovrien R. 1998. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophys J 74: 422-429. (Pubitemid 28041769)
21. Latypov RF, Liu D, Gunasekaran K, Harvey TS, Razinkov VI, Raibekas AA. 2008. Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist. Protein Sci 17:652-663.
22. Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF. 2007. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein Expr Purif 53:63-79.
23. Arakawa T, Timasheff SN. 1984. Mechanism of protein salting in and salting out by divalent cation salts: Balance between hydration and salt binding. Biochemistry 23:5912-5923.
24. Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y, Timasheff SN. 2007. Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects. Biophys Chem 127:1-8. (Pubitemid 46304109)
25. Bright JN, Woolf TB, Hoh JH. 2001. Predicting properties of intrinsically unstructured proteins. Prog Biophys Mol Biol 76:131-173.
26. Goldenberg DP. 2003. Computational simulation of the statistical properties of unfolded proteins. J Mol Biol 326:1615-1633.
27. Berry GC. 1988. Remarks on a relagtion among the intrinsic viscosity, the radius of gyration, and the translational friction coefficient. J Polymer Sci, Part B: Polymer Phys 26:1137-1142.
28. Song Y, Schowen RL, Borchardt RT, Topp EM. 2001. Effect of 'pH' on the rate of asparagine deamidation in polymeric formulations: 'pH'-rate profile. J Pharm Sci 90:141-156.
29. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, Tantos A, Szabo B, Tompa P, Chen J, Uversky VN, Obradovic Z, Dunker AK. 2007. DisProt: The database of disordered proteins. Nucleic Acids Res 35:D786-D793.
30. Vucetic S, Obradovic Z, Vacic V, Radivojac P, Peng K, Iakoucheva LM, Cortese MS, Lawson JD, Brown CJ, Sikes JG, Newton CD, Dunker AK. 2005. Dis-Prot: A database of protein disorder. Bioinformatics 21:137-140.